Statin for severe early-onset placental insufficiency
Treatments studied
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial tests if taking pravastatin (a statin) can improve blood flow to the placenta in pregnant people with either severe early-onset preeclampsia (high blood pressure) or a baby not growing well. The goal is to help the pregnancy last longer and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby
- You are between 24 weeks 0 days and 29 weeks 6 days pregnant
- You have severe early-onset preeclampsia (very high blood pressure before 30 weeks) or the baby is not growing well with abnormal blood flow in the umbilical cord
- Your doctor has decided it is safe to wait and not deliver immediately
- You are not already taking a statin medication
- You do not have lactose intolerance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
This study tests whether dipyridamole, a blood thinner-like medicine, can help manage early-onset preeclampsia in pregnant women. It aims to see if the drug is safe and works to improve pregnancy outcomes.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This trial is testing whether a blood test measuring certain proteins (sFlt-1 and PlGF) can help doctors decide the best time to deliver the baby for women with severe early-onset preeclampsia. The goal is to improve outcomes for both mother and baby.
This trial tests if taking atorvastatin, a common cholesterol medication, after delivery can reduce future heart problems in women who had high blood pressure or preeclampsia during pregnancy. It lasts for 6 months and includes participants who are at least 20 years old.
This trial tests whether adding a statin to progesterone therapy helps young women with early endometrial cancer or atypical endometrial hyperplasia who want to preserve their fertility. It aims to find a better treatment option for those who may not respond well to progesterone alone.
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.